Next Article in Journal
Stability of Glutaraldehyde in Biocide Compositions
Previous Article in Journal
Actin Mutations and Their Role in Disease
Previous Article in Special Issue
Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
Open AccessArticle

A Novel Zinc Chelator, 1H10, Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Zinc Toxicity and AMPK Activation

1
Department of Physiology, Hallym University College of Medicine, Chuncheon 24252, Korea
2
Department of Molecular Biology, Sejong University, Seoul 05006, Korea
3
Department of Neurology, University of Ulsan College of Medicine, Seoul 138-736, Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2020, 21(9), 3375; https://doi.org/10.3390/ijms21093375
Received: 8 April 2020 / Revised: 5 May 2020 / Accepted: 6 May 2020 / Published: 10 May 2020
Previous studies in our lab revealed that chemical zinc chelation or zinc transporter 3 (ZnT3) gene deletion suppresses the clinical features and neuropathological changes associated with experimental autoimmune encephalomyelitis (EAE). In addition, although protective functions are well documented for AMP-activated protein kinase (AMPK), paradoxically, disease-promoting effects have also been demonstrated for this enzyme. Recent studies have demonstrated that AMPK contributes to zinc-induced neurotoxicity and that 1H10, an inhibitor of AMPK, reduces zinc-induced neuronal death and protects against oxidative stress, excitotoxicity, and apoptosis. Here, we sought to evaluate the therapeutic efficacy of 1H10 against myelin oligodendrocyte glycoprotein 35-55-induced EAE. 1H10 (5 μg/kg) was intraperitoneally injected once per day for the entire experimental course. Histological evaluation was performed three weeks after the initial immunization. We found that 1H10 profoundly reduced the severity of the induced EAE and that there was a remarkable suppression of demyelination, microglial activation, and immune cell infiltration. 1H10 also remarkably inhibited EAE-associated blood-brain barrier (BBB) disruption, MMP-9 activation, and aberrant synaptic zinc patch formation. Furthermore, the present study showed that long-term treatment with 1H10 also reduced the clinical course of EAE. Therefore, the present study suggests that zinc chelation and AMPK inhibition with 1H10 may have great therapeutic potential for the treatment of multiple sclerosis. View Full-Text
Keywords: experimental autoimmune encephalomyelitis; zinc; AMPK; multiple sclerosis; microglia; BBB disruption; MMP-9 experimental autoimmune encephalomyelitis; zinc; AMPK; multiple sclerosis; microglia; BBB disruption; MMP-9
Show Figures

Figure 1

MDPI and ACS Style

Choi, B.Y.; Jeong, J.H.; Eom, J.-W.; Koh, J.-Y.; Kim, Y.-H.; Suh, S.W. A Novel Zinc Chelator, 1H10, Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Zinc Toxicity and AMPK Activation. Int. J. Mol. Sci. 2020, 21, 3375.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop